These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16439176)

  • 1. alpha-L-Iduronidase transport in neurites.
    Chen F; Vitry S; Hocquemiller M; Desmaris N; Ausseil J; Heard JM
    Mol Genet Metab; 2006 Apr; 87(4):349-58. PubMed ID: 16439176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of neuropathology in the mouse model of Hurler syndrome.
    Desmaris N; Verot L; Puech JP; Caillaud C; Vanier MT; Heard JM
    Ann Neurol; 2004 Jul; 56(1):68-76. PubMed ID: 15236403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
    Boado RJ; Pardridge WM
    Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Biotechnol Bioeng; 2008 Feb; 99(2):475-84. PubMed ID: 17680664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of enzymatically active human alpha-L-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds.
    Downing WL; Galpin JD; Clemens S; Lauzon SM; Samuels AL; Pidkowich MS; Clarke LA; Kermode AR
    Plant Biotechnol J; 2006 Mar; 4(2):169-81. PubMed ID: 17177794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice.
    Chung S; Ma X; Liu Y; Lee D; Tittiger M; Ponder KP
    Mol Genet Metab; 2007 Feb; 90(2):181-92. PubMed ID: 16979922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal administration of AAV vectors for the treatment of lysosomal storage in the brains of MPS I mice.
    Watson G; Bastacky J; Belichenko P; Buddhikot M; Jungles S; Vellard M; Mobley WC; Kakkis E
    Gene Ther; 2006 Jun; 13(11):917-25. PubMed ID: 16482204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector.
    Kobayashi H; Carbonaro D; Pepper K; Petersen D; Ge S; Jackson H; Shimada H; Moats R; Kohn DB
    Mol Ther; 2005 May; 11(5):776-89. PubMed ID: 15851016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats.
    He X; Li CM; Simonaro CM; Wan Q; Haskins ME; Desnick RJ; Schuchman EH
    Mol Genet Metab; 1999 Jun; 67(2):106-12. PubMed ID: 10356309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α- L-iduronidase gene-based therapy using the phiC31 system to treat mucopolysaccharidose type I mice.
    Stilhano RS; Martin PK; de Melo SM; Samoto VY; Peres GB; da Silva Michelacci YM; da Silva FH; Pereira VG; D'Almeida V; da Cruz AT; Jasiulionis MG; Han SW
    J Gene Med; 2015; 17(1-2):1-13. PubMed ID: 25597593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I.
    Pardridge WM; Boado RJ; Giugliani R; Schmidt M
    BioDrugs; 2018 Apr; 32(2):169-176. PubMed ID: 29442294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I.
    Belur LR; Temme A; Podetz-Pedersen KM; Riedl M; Vulchanova L; Robinson N; Hanson LR; Kozarsky KF; Orchard PJ; Frey WH; Low WC; McIvor RS
    Hum Gene Ther; 2017 Jul; 28(7):576-587. PubMed ID: 28462595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells.
    Kakkis ED; Matynia A; Jonas AJ; Neufeld EF
    Protein Expr Purif; 1994 Jun; 5(3):225-32. PubMed ID: 7950365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of alpha-(L)-iduronidase produced by retrovirally transduced fibroblasts into neuronal and glial cells in vitro.
    Stewart K; Brown OA; Morelli AE; Fairbairn LJ; Lashford LS; Cooper A; Hatton CE; Dexter TM; Castro MG; Lowenstein PR
    Gene Ther; 1997 Jan; 4(1):63-75. PubMed ID: 9068797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of the brain in the dog model of Hurler's syndrome.
    Ciron C; Desmaris N; Colle MA; Raoul S; Joussemet B; Vérot L; Ausseil J; Froissart R; Roux F; Chérel Y; Ferry N; Lajat Y; Schwartz B; Vanier MT; Maire I; Tardieu M; Moullier P; Heard JM
    Ann Neurol; 2006 Aug; 60(2):204-13. PubMed ID: 16718701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and downstream mannose phosphorylation of human recombinant α-L-iduronidase produced in Arabidopsis complex glycan-deficient (cgl) seeds.
    He X; Pierce O; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Gloster TM; Vocadlo DJ; Qian Y; Brooks D; Kermode AR
    Plant Biotechnol J; 2013 Dec; 11(9):1034-43. PubMed ID: 23898885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets are efficient and protective depots for storage, distribution, and delivery of lysosomal enzyme in mice with Hurler syndrome.
    Dai M; Han J; El-Amouri SS; Brady RO; Pan D
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2680-5. PubMed ID: 24550296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.
    Pierce OM; McNair GR; He X; Kajiura H; Fujiyama K; Kermode AR
    Plant Mol Biol; 2017 Dec; 95(6):593-606. PubMed ID: 29119347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.